'Steady Bullish' Options Activity in Pfizer (PFE) Ahead of Q4 Earnings Announcement on Jan. 30th -Susquehanna
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.29 +2.62%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.1%
Revenue Growth %: -1.8%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 7.1%
Revenue Growth %: -1.8%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes "steady bullish" options activity in Pfizer (NYSE: PFE) ahead of fourth quarter earnings on Jan. 30th, as investors purchased ~20,000 Feb 38 Calls and 10,000 Feb 38.5 Calls.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Argus starts SpaceX at Hold, sees record IPO as a multi-year re-rating challenge
- Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of Companies, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
